姜嫣嫣 - 复旦大学

个人简介

教育经历 1986.09 – 1990.06 沈阳药科大学药剂专业本科 1996.09 – 1999.06 沈阳药科大学药剂专业硕士 2001.09 – 2005.06 复旦大学药剂专业博士工作经历 1990.07 – 1992.05 昆明市延安医院药剂科，药师 1992.05 – 1996.08 哈尔滨第五医院，药剂科，药师 1999.07 – 今复旦大学药学院，讲师、副教授、教授

研究领域

纳米技术的药物靶向递释系统药物新剂型与新制剂的研究开发

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

XF Zhang, S Yao, C Liu, YY Jiang*. Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapy. Biomaterials, 2015, 39: 269-281. K Wang, XF Zhang, Y Liu,C Liu, BH Jiang*, YY Jiang*. Tumor penetrability and anti-angiogenesis using iRGD-mediateddelivery of doxorubicin-polymer conjugates. Biomaterials, 2014, 35:8735-8747. K Wang, XF Zhang, LH Zhang, LL Qian, C Liu, JJ Zheng, YY Jiang*. Development of biodegradable polymeric implants of RGD-modifiedPEG-PAMAM-DOX conjugates for long-term intratumoral release. Drug Deliv, 2015, 22(3): 389–399. LL Qian, JJ Zheng, K Wang, Y Tang, XF Zhang , HS Zhang,FP Huang*, YY Pei, YY Jiang*. Cationic coreeshell nanoparticles with carmustine containedwithin O6-benzylguanine shell for glioma therapy. Biomaterials(IF 7.604, 2012), 2013, 34: 8968-8978. SJ Zhu, LL Qian, MH Hong, LH Zhang, YY Pei, YY Jiang(姜嫣嫣)*. RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular cells and tumor cells. Advanced Materials (IF 14.829, 2012).2011, 23: H84–H89. Lihong Zhang, Saijie Zhu, Lili Qian, Yuanying Pei, Yongming Qiu(邱永明)*, Yanyan Jiang(姜嫣嫣)*. RGD-modified PEG-PAMAM-DOX Conjugates : In vitro and In vivo Studies for Glioma. Eur. J. Pharm. Biopharm(IF 3.826, 2012). 2011, 79: 232-240. SJ Zhu, MH Hong, GT Tang, LL Qian, JY Lin, YY Jiang(姜嫣嫣)*, YY Pei. Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. Biomaterials (IF 7.604, 2012), 2010, 31:1360-1371. SJ Zhu, MH Hong, LH Zhang, GT Tang, YY Jiang（姜嫣嫣）*, YY Pei. PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In vitro Evaluation, and In vivo Tumor Accumulation. Pharmaceutical Research (IF 4.742, 2012), 2010, 27: 161-174. YY Jiang, GT Tang, SY Kong, SJ Zhu, YY Pei. PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and non-covalent drug inclusion complex. Journal of drug targeting(IF 2.768, 2012). 2010, 18(5):389-403. Yan-Yan Jiang, Chen Liu, Ming-Huang Hong, Sai-Jie Zhu, and Yuan-Ying Pei. Tumor cell targeting of transferrin-PEG-TNF-α conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation. Bioconjugate Chemistry(IF 4.930, 2011), 2007, 18: 41-49.